StockData
Strata Critical Medical, Inc. logo

Strata Critical Medical, Inc. (SRTA) stock

SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3052% below fair value
$5.24−0.18 (-3.32%)

Close on Nov 17, 2026Market cap $463.57MP/E 10.3Yield –

Strata Critical Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Strata Critical Medical's operating income for the twelve months ending Jun 30, 2026 was -$20.41M. For fiscal 2025 it was -$22.35M. The highest annual figure on record is -$10.36M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.35M–
FY2024Dec 31, 2024-$22.53M–
FY2023Dec 31, 2023-$68.12M–
FY2021Sep 30, 2021-$24.09M–
FY2020Sep 30, 2020-$10.36M–
FY2019Sep 30, 2019-$11.54M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$5.41M–
Q1 FY2026CQ1 2026Mar 31, 2026-$2.97M–
Q4 FY2025CQ4 2025Dec 31, 2025-$6.41M–
Q3 FY2025CQ3 2025Sep 30, 2025-$5.62M–
Q2 FY2025CQ2 2025Jun 30, 2025-$4.64M–
Q1 FY2025CQ1 2025Mar 31, 2025-$5.69M–
Q4 FY2024CQ4 2024Dec 31, 2024-$5.90M–
Q3 FY2024CQ3 2024Sep 30, 2024-$7.09M–
Q2 FY2024CQ2 2024Jun 30, 2024-$12.15M–
Q1 FY2024CQ1 2024Mar 31, 2024-$9.87M–
Q4 FY2023CQ4 2023Dec 31, 2023-$35.63M–
Q3 FY2023CQ3 2023Sep 30, 2023-$7.45M–
Q2 FY2023CQ2 2023Jun 30, 2023-$12.21M–
Q1 FY2023CQ1 2023Mar 31, 2023-$12.83M–
Q4 FY2021CQ3 2021Sep 30, 2021-$9.73M–
Q2 FY2020CQ1 2020Jun 30, 2020-$1.48M–
Q4 FY2019CQ3 2019Sep 30, 2019-$43.05K–

More Strata Critical Medical figures

See a number that looks wrong?